Report Detail

Pharma & Healthcare COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism Market Insights and Forecast to 2026

  • RnM4225177
  • |
  • 13 October, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Medical Foods for Inborn Errors of Metabolism Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type
    • 1.4.2 Amino Acid
    • 1.4.3 Glytactin with GMP
    • 1.4.4 Amino Acid-Modified Infant Formula With Iron
    • 1.4.5 Low Protein Food
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application
    • 1.5.2 Phenylketonuria (PKU)
    • 1.5.3 Maple Syrup Urine Disease (MSUD)
    • 1.5.4 Urea Cycle Disorders
    • 1.5.5 Renal Disease
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Medical Foods for Inborn Errors of Metabolism Market Size, Estimates and Forecasts
    • 2.1.1 Global Medical Foods for Inborn Errors of Metabolism Revenue 2015-2026
    • 2.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales 2015-2026
  • 2.2 Global Medical Foods for Inborn Errors of Metabolism, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Medical Foods for Inborn Errors of Metabolism Competitor Landscape by Players

  • 3.1 Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers
    • 3.1.1 Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers (2015-2020)
    • 3.1.2 Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers
    • 3.2.1 Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2015-2020)
    • 3.2.2 Medical Foods for Inborn Errors of Metabolism Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Medical Foods for Inborn Errors of Metabolism Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Medical Foods for Inborn Errors of Metabolism Revenue in 2019
    • 3.2.5 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Medical Foods for Inborn Errors of Metabolism Price by Manufacturers
  • 3.4 Medical Foods for Inborn Errors of Metabolism Manufacturing Base Distribution, Product Types
    • 3.4.1 Medical Foods for Inborn Errors of Metabolism Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Medical Foods for Inborn Errors of Metabolism Product Type
    • 3.4.3 Date of International Manufacturers Enter into Medical Foods for Inborn Errors of Metabolism Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Type (2015-2020)
    • 4.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2015-2020)
    • 4.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2015-2020)
    • 4.1.3 Medical Foods for Inborn Errors of Metabolism Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Type (2021-2026)
    • 4.2.3 Medical Foods for Inborn Errors of Metabolism Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Medical Foods for Inborn Errors of Metabolism Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Application (2015-2020)
    • 5.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2015-2020)
    • 5.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2015-2020)
    • 5.1.3 Medical Foods for Inborn Errors of Metabolism Price by Application (2015-2020)
  • 5.2 Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Medical Foods for Inborn Errors of Metabolism by Country
    • 6.1.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Country
    • 6.1.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
  • 6.3 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Medical Foods for Inborn Errors of Metabolism by Country
    • 7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country
    • 7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
  • 7.3 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism by Region
    • 8.1.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region
    • 8.1.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
  • 8.3 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Medical Foods for Inborn Errors of Metabolism by Country
    • 9.1.1 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country
    • 9.1.2 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
  • 9.3 Central & South America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism by Country
    • 10.1.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country
    • 10.1.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
  • 10.3 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Nestlé
    • 11.1.1 Nestlé Corporation Information
    • 11.1.2 Nestlé Description and Business Overview
    • 11.1.3 Nestlé Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.1.5 Nestlé Related Developments
  • 11.2 Abbott
    • 11.2.1 Abbott Corporation Information
    • 11.2.2 Abbott Description and Business Overview
    • 11.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.2.5 Abbott Related Developments
  • 11.3 Reckitt Benckiser Group
    • 11.3.1 Reckitt Benckiser Group Corporation Information
    • 11.3.2 Reckitt Benckiser Group Description and Business Overview
    • 11.3.3 Reckitt Benckiser Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.3.5 Reckitt Benckiser Group Related Developments
  • 11.4 Ajinomoto
    • 11.4.1 Ajinomoto Corporation Information
    • 11.4.2 Ajinomoto Description and Business Overview
    • 11.4.3 Ajinomoto Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.4.5 Ajinomoto Related Developments
  • 11.5 Solace Nutrition
    • 11.5.1 Solace Nutrition Corporation Information
    • 11.5.2 Solace Nutrition Description and Business Overview
    • 11.5.3 Solace Nutrition Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.5.5 Solace Nutrition Related Developments
  • 11.6 Primus Pharmaceuticals
    • 11.6.1 Primus Pharmaceuticals Corporation Information
    • 11.6.2 Primus Pharmaceuticals Description and Business Overview
    • 11.6.3 Primus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.6.5 Primus Pharmaceuticals Related Developments
  • 11.7 BioMarin Pharmaceutical
    • 11.7.1 BioMarin Pharmaceutical Corporation Information
    • 11.7.2 BioMarin Pharmaceutical Description and Business Overview
    • 11.7.3 BioMarin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.7.5 BioMarin Pharmaceutical Related Developments
  • 11.8 Danone SA
    • 11.8.1 Danone SA Corporation Information
    • 11.8.2 Danone SA Description and Business Overview
    • 11.8.3 Danone SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.8.5 Danone SA Related Developments
  • 11.9 Galen Limited
    • 11.9.1 Galen Limited Corporation Information
    • 11.9.2 Galen Limited Description and Business Overview
    • 11.9.3 Galen Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.9.5 Galen Limited Related Developments
  • 11.10 PKU-MDMIL
    • 11.10.1 PKU-MDMIL Corporation Information
    • 11.10.2 PKU-MDMIL Description and Business Overview
    • 11.10.3 PKU-MDMIL Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.10.5 PKU-MDMIL Related Developments
  • 11.1 Nestlé
    • 11.1.1 Nestlé Corporation Information
    • 11.1.2 Nestlé Description and Business Overview
    • 11.1.3 Nestlé Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Products Offered
    • 11.1.5 Nestlé Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Medical Foods for Inborn Errors of Metabolism Market Estimates and Projections by Region
    • 12.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Regions 2021-2026
  • 12.2 North America Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
    • 12.2.1 North America: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
    • 12.2.2 North America: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
    • 12.2.3 North America: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
    • 12.3.2 Europe: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Medical Foods for Inborn Errors of Metabolism Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Medical Foods for Inborn Errors of Metabolism Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids.
    Market Analysis and Insights: Global Medical Foods for Inborn Errors of Metabolism Market
    The global Medical Foods for Inborn Errors of Metabolism market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    Global Medical Foods for Inborn Errors of Metabolism Scope and Segment
    Medical Foods for Inborn Errors of Metabolism market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Foods for Inborn Errors of Metabolism market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
    The following manufacturers are covered in this report:
    Nestlé
    Abbott
    Reckitt Benckiser Group
    Ajinomoto
    Solace Nutrition
    Primus Pharmaceuticals
    BioMarin Pharmaceutical
    Danone SA
    Galen Limited
    PKU-MDMIL
    Medical Foods for Inborn Errors of Metabolism Breakdown Data by Type
    Amino Acid
    Glytactin with GMP
    Amino Acid-Modified Infant Formula With Iron
    Low Protein Food
    Others
    Medical Foods for Inborn Errors of Metabolism Breakdown Data by Application
    Phenylketonuria (PKU)
    Maple Syrup Urine Disease (MSUD)
    Urea Cycle Disorders
    Renal Disease
    Others
    Regional and Country-level Analysis
    The Medical Foods for Inborn Errors of Metabolism market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Medical Foods for Inborn Errors of Metabolism market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Medical Foods for Inborn Errors of Metabolism Market Share Analysis


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism. Industry analysis & Market Report on COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism is a syndicated market report, published as COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,696.98
    5,393.96
    2,976.00
    5,952.01
    368,805.50
    737,611.00
    256,634.35
    513,268.70
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report